Autopsy report · NCT02669043

Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects

“Funding ended.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 7 months before it stopped.
• 8 participants enrolled.
• Results were posted on the registry 0 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Depression

Interventions

Ketamine

Participants

8

Sites

1

Countries

United States

Trials that died the same way

• Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
  “Funding ended prematurely” (89% match in meaning)
• Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief
  “Funding duration ended.” (88% match in meaning)
• Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)
  “funding ending” (87% match in meaning)
• Role of FCI in the Detection of Proctosigmoiditis Caused by IBD
  “Funding period ended” (86% match in meaning)
• Probiotics and the Gut Microbiome in Obese Hispanic Youth
  “Funds ended.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.